Sapporo Breweries Ltd. engages in the manufacture and sale of alcoholic beverages such as wine, beer, shochu (Japanese distilled beverage), and Western liquor. The company was founded on July 1, 2003 and is headquartered in Tokyo, Japan.

Shanghai Xinhao Biotechnology Co., Ltd., established on 2010-07-01, Business scope includes technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer;Laboratory Equipment Sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstanding incubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.

Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.

La Jolla Institute for Allergy & Immunology is an American private company located in La Jolla, CA. The firm operates as a biomedical research institute helps in understanding of immune system disease. It was founded by Steve Pontell. Erica Saphire is currently the CEO of the company.\nThe company says this about itself: The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

The Rural Development Administration (Korean: 농촌진흥청; Hanja: 農村振興廳, RDA) is one of an agriculture organizations in South Korea and is run under the Ministry of Agriculture, Food and Rural Affairs. The headquarters are in Wansan-gu, Jeonju.

Our vision is to provide a capital efficient and flexible platform where emerging companies can transform the scientific discoveries of today into the breakthrough healthcare products of tomorrow. To accelerate scientific discovery, business, financial and operational obstacles need to be removed so that companies can do what they do best, focus on the science and bringing innovative solutions to patients.

Versitech Ltd. is a Hong Kong Chinese company located in Hong Kong and ultimately controlled by the Government of Hong Kong Special Administrative Region. The firm provides business services.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following segments: Pharmaceutical Business; and Medical and Research Equipment Business. The Pharmaceutical Business segment deals with the manufacture, purchase, and sale of ethical drugs, active pharmaceutical ingredients, and raw materials. The Medical and Research Equipment Business segment sells medical devices and laboratory equipment. The company was founded by Shin Ashida on September 13, 1975 and is headquartered in Ashiya, Japan.

Qingdao Huanuo Storage Co., Ltd., established on 2002-08-29, Business scope includes general business items:Warehousing Services(Does not contain dangerous goods). (The above scope needs to be licensed to operate,Operate with a license).

Bionor Immuno AS engages in the research and development of biomedicine. It also owns and manages shares and other securities. The company was founded on July 14, 2000 and is headquartered in Oslo, Norway.

Yu Chuantang (Jian) ​​Biotechnology Co., Ltd., established on 2012-07-04, Business scope includes biological products,hygiene products,disinfection products,Healthy food,cosmetic,Pharmaceutical Technology Research,technology development,Technology transfer;hygiene products,cleaning supplies,Class I medical device,cosmetic,Daily necessities,crafts,electronic product,Chemical raw materials and products(Except for dangerous chemicals and precursor chemicals),Stationery,Healthy food,ginseng,antler,Chinese herbal medicine,Souvenirs,Agricultural and sideline food,Prepackaged food and bulk food sales;Business Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Mingxin High-Tech Development Co., Ltd., established on 2001-09-17, Business scope includes technology development,technology transfer,technical consulting,Technical Services;sale of building materials,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),Instrumentation,Equipment;market survey;Economic and Trade Consulting;Accounting Consulting;Conference Services;Undertake exhibition and display activities;Organize cultural and artistic exchange activities(without show);buisness planning;investment management.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 6,500 employees and serves more than 85,000 research and industry customers worldwide through its global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.